文献速递复苏、休克与脓毒症创伤与烧伤

平民创伤患者早期输注冷藏全血能否减少成分血治疗需求:一项系统评价

Does early transfusion of cold-stored whole blood reduce the need for component therapy in civilian trauma patients? A systematic review.
PubMed 文献 · J Trauma Acute Care Surg · 2024-09-27
一句话结论平民创伤失血性休克患者初始复苏使用冷藏全血后,成分血治疗使用似乎减少,但研究异质性强,需进一步研究。

本系统评价按PRISMA指南检索Medline、EMBASE和Transfusion Evidence Library,纳入报告创伤失血性休克患者接受全血初始治疗后24小时血制品使用情况的11项研究(n=4,792)。研究设计、干预和结局存在异质性。7项研究报告全血干预组24小时输血需求较对照成分血治疗组显著降低,3项报告两组无显著差异,1项报告全血组24小时输血需求增加。作者认为,平民创伤失血性休克患者全血初始复苏后成分血治疗使用似乎减少,但尚需进一步研究回答这一重要实践问题。

要点

  • 系统评价纳入11项研究共4,792例平民创伤失血性休克患者,评估早期冷藏全血复苏能否减少伤后24小时成分血治疗需求。
  • 7项研究报告全血干预组24小时输血需求较对照成分血治疗组显著降低。
  • 3项研究报告全血组与成分血治疗组24小时输血需求无显著差异。
  • 1项研究报告全血组24小时输血需求增加。
  • 研究设计、干预与结局存在异质性,作者认为需进一步研究。

适用人群与场景

  • 平民创伤患者,处于失血性休克并接受全血初始治疗。
  • 纳入标准:报告创伤失血性休克患者接受全血初始治疗后24小时血制品使用数据的研究。

处置流程与药物剂量

  • 早期复苏使用冷藏全血治疗,评估其对伤后24小时成分血治疗需求的影响。

研究设计与关键结果

  • 系统评价:共检索到2,150项研究,11项研究(n=4,792)符合纳入标准。
  • 研究设计、干预和结局存在异质性。
  • 7项研究报告全血干预组24小时输血需求较对照成分血治疗组显著降低。
  • 3项研究报告全血组与成分血治疗组之间无显著差异。
  • 1项研究报告全血组24小时输血需求增加。

证据类型、等级与局限

  • 证据类型:系统评价。
  • 证据等级:Level IV。
  • 局限:研究设计、干预和结局存在异质性;作者认为需进一步研究回答这一重要实践问题。

对床旁实践的改变

  • 作者认为,平民创伤失血性休克患者全血初始复苏后成分血治疗使用似乎减少。
  • 作者认为,尚需进一步研究回答早期冷藏全血复苏能否减少成分血治疗需求这一重要实践问题。

指南或共识出处

  • PROSPERO注册号:CRD42023422173。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Civilian acute trauma care has advanced in recent decades; however, traumatic injury remains the leading cause of death in individuals aged 15 to 29 years in the United States and worldwide. Uncontrolled hemorrhage is the leading preventable cause of death in trauma patients, with up to half of these deaths occurring before reaching a medical facility. The timely application of hemorrhage control measures is critical to enhance the survivability of trauma patients and is one of the major challenges faced by medical providers in austere environments. The purpose of this review is to explore if early resuscitation with cold-stored whole blood therapy reduces the need for component therapy in the first 24 hours postinjury in the civilian population.

METHODS: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we performed a systematic literature search in Medline, EMBASE, and Transfusion Evidence Library for studies reporting data on 24-hour blood product usage in trauma patients in hemorrhagic shock receiving initial therapy with whole blood. Two reviewers independently performed the selection of eligible studies.

RESULTS: Of a total of 2,150 identified studies, 11 studies (n = 4,792) met the inclusion criteria. There was heterogeneity in the study design, interventions, and outcomes. Seven studies reported a statistically significant decrease in 24-hour transfusion requirements in the whole blood intervention group in comparison with the control component therapy group. Three studies reported no significant difference between the two groups. One of the studies reported an increase in 24-hour transfusion requirements in the whole blood group.

CONCLUSION: Overall, there appears to be a decrease in component therapy use following initial resuscitation with whole blood in trauma patients with hemorrhagic shock. However, further research is needed to address this important practical question (PROSPERO registration no. CRD42023422173).

LEVEL OF EVIDENCE: Systematic Review; Level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Risha M, Alotaibi A, Smith S, et al. Does early transfusion of cold-stored whole blood reduce the need for component therapy in civilian trauma patients? A systematic review. J Trauma Acute Care Surg. 2024. PMID: 39327655. doi:10.1097/TA.0000000000004429

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。